Mutation analysis of the PTEN/MMAC1 gene in lung cancer (original) (raw)
- Original Paper
- Published: 22 September 1998
- Eric J Biesterveld1,
- Yoshitaka Sekido1,2,
- Kwun Fong1 nAff5,
- Sabeeha Muneer1,
- Ignacio I Wistuba1,
- Sara Milchgrub4,
- Ruth Brezinschek1,
- Arvind Virmani1,4,
- Adi F Gazdar1,4 &
- …
- John D Minna1,2,3
Oncogene volume 17, pages 1557–1565 (1998)Cite this article
- 1352 Accesses
- 12 Altmetric
- Metrics details
Abstract
We studied PTEN/MMAC1, a newly discovered candidate tumor suppressor gene at 10q23.3, for mutations in lung cancer. One hundred and thirty-six lung cancer cell line DNAs (66 small cell lung cancers, SCLC, 61 non-small cell lung cancers, NSCLC, four mesotheliomas, five extrapulmonary small cell cancers) were analysed for PTEN/MMAC1 homozygous deletions and five (8%) SCLC lines showed homozygous deletions interrupting the PTEN/MMAC1 gene. Using single stranded conformation polymorphism (SSCP) analysis, we screened the PTEN/MMAC1 open reading frame of 53 lung cancer cell line cDNAs for point mutations and found that 3/35 SCLCs and 3/18 NSCLCs contained homozygous amino acid sequence altering mutations. Northern blot analysis revealed that expression of the PTEN/MMAC1 gene was considerably lower in all the tumor cell lines with point mutations while no expression was detected for cell lines with PTEN/MMAC1 homozygous deletions. Mutation analysis of 22 uncultured, microdissected, primary SCLC tumors and metastases showed two silent mutations, and two apparent homozygous deletions. We also discovered a processed pseudogene (PTEN2) which has 98.5% nt identity to PTEN/MMAC1, that needs to be accounted for in cDNA mutation analysis. Our findings suggest that genetic abnormalities of the PTEN/MMAC1 gene are only involved in a relatively small subset of lung cancers.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Author notes
- Kwun Fong
Present address: Department of Thoracic Medicine, The Prince Charles Hospital, Rode Road, Chermside, 4032, Brisbane, Australia
Authors and Affiliations
- Hamon Center for Therapeutic Oncology Research, University of Texas, Southwestern Medical Center, Dallas, 75235, Texas, USA
Eva Forgacs, Eric J Biesterveld, Yoshitaka Sekido, Kwun Fong, Sabeeha Muneer, Ignacio I Wistuba, Ruth Brezinschek, Arvind Virmani, Adi F Gazdar & John D Minna - Department of Internal Medicine, University of Texas, Southwestern Medical Center, Dallas, 75235, Texas, USA
Yoshitaka Sekido & John D Minna - Department of Pharmacology, University of Texas, Southwestern Medical Center, Dallas, 75235, Texas, USA
John D Minna - Department of Pathology, University of Texas, Southwestern Medical Center, Dallas, 75235, Texas, USA
Sara Milchgrub, Arvind Virmani & Adi F Gazdar
Authors
- Eva Forgacs
You can also search for this author inPubMed Google Scholar - Eric J Biesterveld
You can also search for this author inPubMed Google Scholar - Yoshitaka Sekido
You can also search for this author inPubMed Google Scholar - Kwun Fong
You can also search for this author inPubMed Google Scholar - Sabeeha Muneer
You can also search for this author inPubMed Google Scholar - Ignacio I Wistuba
You can also search for this author inPubMed Google Scholar - Sara Milchgrub
You can also search for this author inPubMed Google Scholar - Ruth Brezinschek
You can also search for this author inPubMed Google Scholar - Arvind Virmani
You can also search for this author inPubMed Google Scholar - Adi F Gazdar
You can also search for this author inPubMed Google Scholar - John D Minna
You can also search for this author inPubMed Google Scholar
Rights and permissions
About this article
Cite this article
Forgacs, E., Biesterveld, E., Sekido, Y. et al. Mutation analysis of the PTEN/MMAC1 gene in lung cancer.Oncogene 17, 1557–1565 (1998). https://doi.org/10.1038/sj.onc.1202070
- Received: 29 January 1998
- Revised: 20 April 1998
- Accepted: 21 April 1998
- Published: 22 September 1998
- Issue Date: 24 September 1998
- DOI: https://doi.org/10.1038/sj.onc.1202070